Search results for:
Ondine’s President and CTO receives IPA Lifetime Achievement Award
Ondine’s Dr. Nicolas Loebel receives IPA Lifetime Achievement Award for photodisinfection advancements Vancouver, British Columbia, Canada - October 31, 2022 Nicolas Loebel, Nicolas Loebel, President &Chief Technology Officer at Ondine Biomedical Inc. Dr. Nicolas Loebel, President and Chief Technology officer of Ondine Biomedical [...]
Ondine presents new efficacy data against MRSA
Ondine Biomedical presents research showing its Steriwave photodisinfection treatment is highly effective against multidrug-resistant strains of MRSA Vancouver, British Columbia, Canada - October 19, 2022 Photodisinfection technology shows great promise as a new method for fighting drug-resistant infections amidst rising rates of antimicrobial resistance. Ondine [...]
Steriwave™ cuts SSI risk by 47% at major hospital
New study shows nasal photodisinfection cuts surgical site infection risk by 47% and mortality by nearly 60% Vancouver, British Columbia, Canada - October 19, 2022 Surgical site infections reduced by an average of 47% across all surgery types (P=0.01). Most significant impact seen in cardiac [...]
The Ottawa Hospital pilots pre-surgical nasal disinfection
The Ottawa Hospital pilots pre-surgical nasal disinfection for all spine surgery patients to reduce infections Vancouver, British Columbia, Canada - September 23, 2022 The Ottawa Hospital has chosen to use photodisinfection technology developed by Canadian life sciences company, Ondine Biomedical. Nasal decolonization has been recommended [...]
Photodisinfection successfully eradicates pathogens associated with replacement joint infections
New research shows photodisinfection successfully eradicates pathogens associated with replacement joint infections Vancouver, British Columbia, Canada - September 20, 2022 A research team in Zurich, Switzerland has presented results from an in vitro study showing that photodisinfection achieved >99.99% eradication (4-7 log10 kill) of the [...]
Ondine’s photodisinfection kills ESKAPE pathogens
Data presented at World AMR Congress shows Ondine Biomedical’s photodisinfection effective against antibiotic-resistant ESKAPE pathogens Vancouver, British Columbia, Canada - September 7, 2022 Canadian life sciences company, Ondine Biomedical Inc. (LON: OBI), this week presented an in vitro study at the World Anti-Microbial Resistance [...]
Ondine reports successful US Phase 2 trial data
Ondine Biomedical reports successful topline data from Phase 2 nasal photodisinfection trial Vancouver, British Columbia, Canada - September 6, 2022 Results show a single, 5-minute treatment of nasal photodisinfection significantly reduces Staphylococcus aureus, a major cause of surgical site infections, in pre-surgical patients Top line results [...]
Ondine Receives Innovation Award of Excellence at ICPIC 2021
Ondine Receives Innovation Award of Excellence at World-leading Infection Conference, ICPIC 2021, for Photodisinfection Efficacy Results against COVID-19 Virus Variants including Delta Ondine’s nasal photodisinfection technology has been shown to eliminate the RNA signature of SARS-CoV-2, including the dominant Delta variant, in in vitro research. The research [...]
Preventing COVID-19 with Photodisinfection
Preventing COVID-19 with Photodisinfection – New Results Presented at European Society of Photobiology Results presented at 2021 European Society of Photobiology conference demonstrate Ondine’s broad-spectrum nasal photodisinfection technology eliminates COVID at both genomic and spike protein levels. Nasal decolonization is recommended by the [...]
Presenting SARS-CoV-2 results at ESP2021
Ondine to present SARS-CoV-2 results at the 19th Congress of the European Society of Photobiology Ondine's technology platform is capable of painlessly and rapidly destroying a broad spectrum of bacteria, fungi, and viruses — including SARS-CoV-2 — without generating resistance. Vancouver, [...]
For Media Information
Simon Vane Percy
Amanda Bernard
